![Kenneth F. Boehm](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth F. Boehm
Keine laufenden Positionen mehr
Profil
Kenneth F.
Boehm held several positions in human resources throughout his career.
He started as the Vice President-Human Resources at Synopsys, Inc. from 2010 to 2013.
He then worked as the Senior Vice President-Human Resources at Pharmacyclics LLC.
In 2013, he became the Vice President-Human Resources at Polycom, Inc. until 2014.
From 2014 to 2015, he served as the Senior Vice President-Human Resources at E2open LLC.
Mr. Boehm also worked as the Vice President-Human Resources at Gilead Sciences, Inc. from 2009 to 2020.
Prior to that, he was the Vice President-Human Resource at PalmSource, Inc. from 2002 to 2005 and the Vice President-Human Resources at CV Therapeutics, Inc. from 2005 to 2009.
He later became the Vice President-Human Resources at Aimmune Therapeutics, Inc. from 2015 to 2018.
Currently, he is the Senior Vice President-Human Resources at CymaBay Therapeutics, Inc. from 2019 to 2024.
Mr. Boehm obtained his undergraduate degree from the University of California, Los Angeles.
He also holds a doctorate degree from Golden Gate University and an MBA from Pepperdine University.
Ehemalige bekannte Positionen von Kenneth F. Boehm
| Unternehmen | Position | Ende |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Personalreferent | 22.03.2024 |
| GILEAD SCIENCES, INC. | Personalreferent | 01.05.2020 |
| AIMMUNE THERAPEUTICS, INC. | Personalreferent | 01.04.2018 |
| E2OPEN INC | Personalreferent | 01.08.2015 |
| POLYCOM INC | Personalreferent | 01.05.2014 |
Ausbildung von Kenneth F. Boehm
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Synopsys, Inc.
 Synopsys, Inc. Packaged SoftwareTechnology Services Develops semiconductor intellectual property and electronic design automation software solutions | Technology Services |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Polycom, Inc.
 Polycom, Inc. Electronics/AppliancesConsumer Durables Provides solutions for video, voice, data and web communication | Consumer Durables |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
PalmSource, Inc.
 PalmSource, Inc. Packaged SoftwareTechnology Services Develops and licenses platform software | Technology Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Golden Gate University
 Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pepperdine University
 Pepperdine University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
E2open LLC
 E2open LLC Packaged SoftwareTechnology Services Develops cloud-based supply chain platform | Technology Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of desensitization treatments for peanut and food allergies | Health Technology |
